Patents by Inventor Haixia Wang

Haixia Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulators of LXR
    Patent number: 7482366
    Abstract: Compounds of the invention, such as compounds of formula (I): where n, m, A, B, R1, R2, R3, R4 and R5 are defined herein, are useful as modulators of the activity of liver X receptors. Pharmaceutical compositions containing the compounds and methods of using the compounds are also disclosed.
    Type: Grant
    Filed: July 24, 2004
    Date of Patent: January 27, 2009
    Assignee: X-Ceptor Therapeutics, Inc.
    Inventors: Christopher D Bayne, Alan T Johnson, Shao-Po Lu, Raju Mohan, Michael C Nyman, Edwin J Schweiger, William C Stevens, Jr., Haixia Wang, Yinong Xie
  • Pyrazolyl-Amino-Substituted Pyrimidines and Their Use in the Treatment of Cancer
    Publication number: 20080194606
    Abstract: This invention relates to novel compounds having the formula (I), and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment for cancer.
    Type: Application
    Filed: May 4, 2006
    Publication date: August 14, 2008
    Applicant: ASTRAZENECA
    Inventors: David Scott, Haixia Wang, Tao Wang
  • Modulators Of Nuclear Receptors
    Publication number: 20080119488
    Abstract: Compounds of the invention, such as compounds of formula (I), where n, m, A, R1, R2, R3, R4 and R5 are defined herein, are useful as modulators of the activity of liver X receptors. Pharmaceutical compositions containing the compounds and methods of using the compounds are also disclosed.
    Type: Application
    Filed: July 24, 2005
    Publication date: May 22, 2008
    Applicant: EXELIXIS, INC.
    Inventors: Christopher D. Bayne, Alan T. Johnson, Shao-Po Lu, Raju Mohan, Michael C. Nyman, Edwin J. Schweiger, William C. Stevens, Haixia Wang, Yinong Xie, Lynne Canne Bannen, Diva Sze-Ming Chan, Ping Huang, Vasu Jammalamadaka, Richard G. Khoury, Morrison B. Mac, Jason Jevious Parks, Yong Wang, Wei Xu
  • Novel Bicyclic Compounds As Modulators of Androgen Receptor Function And Method
    Publication number: 20080096954
    Abstract: There are disclosed bicyclic compounds according to formula I, pharmaceutical compositions containing such compounds and methods of using such compounds in the treatment of androgen receptor-associated conditions, such as age-related diseases, for example sarcopenia, wherein R1, R2, R5, X and n are defined herein.
    Type: Application
    Filed: October 31, 2007
    Publication date: April 24, 2008
    Applicant: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: James Li, Lawrence Hamann, Haixia Wang
  • Pyrazole derivatives as inhibitors of receptor tyrosone kinases
    Publication number: 20070142413
    Abstract: Compounds of formula (I): and their use in the inhibition of Trk activity are described.
    Type: Application
    Filed: November 15, 2004
    Publication date: June 21, 2007
    Inventors: Michael Block, John Lee, David Scott, Haixia Wang, Tao Wang, Dingwei Yu, Yongxin Han, John Josey, Bin Wang
  • Novel bicyclic compounds as modulators of androgen receptor function and method
    Publication number: 20070004717
    Abstract: The present invention relates to bicyclic compounds according to formula I, pharmaceutical compositions containing such compounds and methods of using such compounds in the treatment of androgen receptor-associated conditions, such as age-related diseases, for example sarcopenia, wherein R1, R2, R5, X and n are defined herein.
    Type: Application
    Filed: March 2, 2005
    Publication date: January 4, 2007
    Inventors: James Li, Lawrence Hamann, Haixia Wang
  • Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
    Publication number: 20060287357
    Abstract: Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds have the structure: or stereoisomers or prodrugs or pharmaceutically acceptable salts thereof, wherein W, L, R3, R3a, R3b and R4 are defined herein.
    Type: Application
    Filed: June 7, 2006
    Publication date: December 21, 2006
    Inventors: James Li, Lawrence Hamann, Haixia Wang, Zheming Ruan, Christopher Cooper, Jun Li, Jeffrey Robl
  • Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
    Publication number: 20060281750
    Abstract: Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds have the structure: W-L-Z ??(I) or stereoisomers or prodrugs or pharmaceutically acceptable salts thereof, wherein W, L and Z are defined herein.
    Type: Application
    Filed: June 7, 2006
    Publication date: December 14, 2006
    Inventors: James Li, Lawrence Hamann, Haixia Wang
  • Inhibitors of 11-beta hydroxysteroid dehydrogenase type I
    Publication number: 20060235028
    Abstract: Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds have the structure: or stereoisomers or prodrugs or pharmaceutically acceptable salts thereof, wherein G, L, Q, Z, R6, R7, and R8 are defined herein.
    Type: Application
    Filed: April 12, 2006
    Publication date: October 19, 2006
    Inventors: James Li, Lawrence Hamann, Zheming Ruan, Christopher Cooper, Shung Wu, Ligaya Simpkins, Haixia Wang, Akbar Nayeem, Stanley Krystek
  • Modulators of LXR
    Publication number: 20050080111
    Abstract: Compounds of the invention, such as compounds of formula (I): where n, m, A, B, R1, R2, R3, R4 and R5 are defined herein, are useful as modulators of the activity of liver X receptors. Pharmaceutical compositions containing the compounds and methods of using the compounds are also disclosed.
    Type: Application
    Filed: July 24, 2004
    Publication date: April 14, 2005
    Applicant: X-Ceptor Therapeutics, Inc.
    Inventors: Christopher Bayne, Alan Johnson, Shao-Po Lu, Raju Mohan, Michael Nyman, Edwin Schweiger, William Stevens, Haixia Wang, Yinong Xie